Published on
May 26, 2025
FDA suspends new application fees
THE Food and Drug Administration (FDA) said it suspended the new registration and assessment fees for medical products after legislators said they were modified without sufficient consultation. In a briefing at the House of Representatives, FDA Director- …
Source:
Business World
-
Neutral
